Cargando…

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes

The time trade-off (TTO) valuation technique is widely used to determine utility values of health outcomes to inform quality-adjusted life-year (QALY) calculations for use in economic evaluation. Protocols for implementing TTO vary in aspects such as the trade-off framework, iteration procedure and...

Descripción completa

Detalles Bibliográficos
Autores principales: Oppe, Mark, Rand-Hendriksen, Kim, Shah, Koonal, Ramos‐Goñi, Juan M., Luo, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023738/
https://www.ncbi.nlm.nih.gov/pubmed/27084198
http://dx.doi.org/10.1007/s40273-016-0404-1
_version_ 1782453676922634240
author Oppe, Mark
Rand-Hendriksen, Kim
Shah, Koonal
Ramos‐Goñi, Juan M.
Luo, Nan
author_facet Oppe, Mark
Rand-Hendriksen, Kim
Shah, Koonal
Ramos‐Goñi, Juan M.
Luo, Nan
author_sort Oppe, Mark
collection PubMed
description The time trade-off (TTO) valuation technique is widely used to determine utility values of health outcomes to inform quality-adjusted life-year (QALY) calculations for use in economic evaluation. Protocols for implementing TTO vary in aspects such as the trade-off framework, iteration procedure and its administration model and method, training of respondents and interviewers, and quality control of data collection. The most widely studied and utilized TTO valuation protocols are the Measurement and Valuation of Health (MVH) protocol, the Paris protocol and the EuroQol Valuation Technology (EQ-VT) protocol, all developed by members of the EuroQol Group. The MVH protocol and its successor, the Paris protocol, were developed for valuation of EQ-5D-3L health states. Both protocols were designed for a trained interviewer to elicit preferences from a respondent using the conventional TTO framework with a fixed time horizon of 10 years and an iteration procedure combining bisection and titration. Developed for valuation of EQ-5D-5L health states, the EQ-VT protocol adopted a composite TTO framework and made use of computer technology to facilitate data collection. Training and monitoring of interviewers and respondents is a pivotal component of the EQ-VT protocol. Research is underway aiming to further improve the EuroQol protocols, which form an important basis for the current practice of health technology assessment in many countries.
format Online
Article
Text
id pubmed-5023738
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-50237382016-09-27 EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes Oppe, Mark Rand-Hendriksen, Kim Shah, Koonal Ramos‐Goñi, Juan M. Luo, Nan Pharmacoeconomics Practical Application The time trade-off (TTO) valuation technique is widely used to determine utility values of health outcomes to inform quality-adjusted life-year (QALY) calculations for use in economic evaluation. Protocols for implementing TTO vary in aspects such as the trade-off framework, iteration procedure and its administration model and method, training of respondents and interviewers, and quality control of data collection. The most widely studied and utilized TTO valuation protocols are the Measurement and Valuation of Health (MVH) protocol, the Paris protocol and the EuroQol Valuation Technology (EQ-VT) protocol, all developed by members of the EuroQol Group. The MVH protocol and its successor, the Paris protocol, were developed for valuation of EQ-5D-3L health states. Both protocols were designed for a trained interviewer to elicit preferences from a respondent using the conventional TTO framework with a fixed time horizon of 10 years and an iteration procedure combining bisection and titration. Developed for valuation of EQ-5D-5L health states, the EQ-VT protocol adopted a composite TTO framework and made use of computer technology to facilitate data collection. Training and monitoring of interviewers and respondents is a pivotal component of the EQ-VT protocol. Research is underway aiming to further improve the EuroQol protocols, which form an important basis for the current practice of health technology assessment in many countries. Springer International Publishing 2016-04-15 2016 /pmc/articles/PMC5023738/ /pubmed/27084198 http://dx.doi.org/10.1007/s40273-016-0404-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Practical Application
Oppe, Mark
Rand-Hendriksen, Kim
Shah, Koonal
Ramos‐Goñi, Juan M.
Luo, Nan
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
title EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
title_full EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
title_fullStr EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
title_full_unstemmed EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
title_short EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
title_sort euroqol protocols for time trade-off valuation of health outcomes
topic Practical Application
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023738/
https://www.ncbi.nlm.nih.gov/pubmed/27084198
http://dx.doi.org/10.1007/s40273-016-0404-1
work_keys_str_mv AT oppemark euroqolprotocolsfortimetradeoffvaluationofhealthoutcomes
AT randhendriksenkim euroqolprotocolsfortimetradeoffvaluationofhealthoutcomes
AT shahkoonal euroqolprotocolsfortimetradeoffvaluationofhealthoutcomes
AT ramosgonijuanm euroqolprotocolsfortimetradeoffvaluationofhealthoutcomes
AT luonan euroqolprotocolsfortimetradeoffvaluationofhealthoutcomes